| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/03/2015 | US8969040 Pharmaceutical agent comprising anti-BMP9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia |
| 03/03/2015 | US8969037 Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene |
| 03/03/2015 | US8969036 Process for obtaining antibodies |
| 03/03/2015 | US8969024 Compositions and methods comprising binding proteins for adalimumab |
| 03/03/2015 | US8969013 Method for identifying lineage-related antibodies |
| 03/03/2015 | US8969012 Immunogens for treatment of neoplastic and infectious disease |
| 03/03/2015 | US8968742 Antibody drug conjugates (ADC) that bind to 158P1D7 proteins |
| 03/03/2015 | US8968741 Anti-CD22 antibodies and immunoconjugates and methods of use |
| 03/03/2015 | US8968740 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1 |
| 03/03/2015 | US8968739 Antibody and methods for selective inhibition of T-cell responses |
| 03/03/2015 | US8968738 Methods of treating autoimmune diseases with anti-FcεRI antibodies |
| 03/03/2015 | US8968736 Human antibodies to GFRα3 and methods of use thereof |
| 03/03/2015 | US8968735 Compositions and methods including a recombinant human MAB that promotes CNS remyelination |
| 03/03/2015 | US8968734 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies |
| 03/03/2015 | US8968732 Methods of treating pain using an IL-31 monoclonal antibody |
| 03/03/2015 | US8968731 Treatment of uveitis |
| 03/03/2015 | US8968730 FcγRIIB specific antibodies and methods of use thereof |
| 03/03/2015 | US8968720 Heat shock protein GP96 vaccination and methods of using same |
| 02/26/2015 | WO2015027082A1 Tgf-beta receptor type ii variants and uses thereof |
| 02/26/2015 | WO2015026934A1 Bruton's tyrosine kinase as anti-cancer drug target |
| 02/26/2015 | WO2015026907A1 Anti-prlr antibodies and uses thereof |
| 02/26/2015 | WO2015026892A1 Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof |
| 02/26/2015 | WO2015026684A1 Modulation of tumor immunity |
| 02/26/2015 | WO2015026634A1 Treating cancer with a combination of a pd-1 antagonist and dinaciclib |
| 02/26/2015 | WO2015026606A1 Antibody identification by lineage analysis |
| 02/26/2015 | WO2015025968A1 Mycoplasma pneumoniae immunological detection method and kit |
| 02/26/2015 | WO2015025900A1 Anti-influenza virus-neutralizing antibody |
| 02/26/2015 | WO2015025786A1 HUMAN ANTIBODY κ TYPE LIGHT CHAIN COMPLEX-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME |
| 02/26/2015 | WO2015025054A1 Dye-specific antibodies for prestained molecular weight markers and methods producing the same |
| 02/26/2015 | WO2015024977A1 CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING α-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES |
| 02/26/2015 | WO2015024896A1 Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography |
| 02/26/2015 | WO2015024060A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/26/2015 | WO2015024042A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/26/2015 | WO2014006217A9 Dimeric protein with triple mutations |
| 02/26/2015 | US20150059009 Methods for making fully human bispecific antibodies using a common light chain |
| 02/26/2015 | US20150057437 Anti-cd40 antibody mutants |
| 02/26/2015 | US20150057436 Humanized antibodies |
| 02/26/2015 | US20150057191 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 02/26/2015 | US20150056680 Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses |
| 02/26/2015 | US20150056655 Expression constructs and methods for expressing polypeptides in eukaryotic cells |
| 02/26/2015 | US20150056635 Systems and Methods for Anti-PAX8 Antibodies |
| 02/26/2015 | US20150056294 Methods and compositions for preparing a silk microsphere |
| 02/26/2015 | US20150056238 Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof |
| 02/26/2015 | US20150056235 Materials and methods for respiratory disease control in canines |
| 02/26/2015 | US20150056223 Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease |
| 02/26/2015 | US20150056222 Anti-prlr antibodies and uses thereof |
| 02/26/2015 | US20150056221 Anti-prlr antibodies and uses thereof |
| 02/26/2015 | US20150056218 P97 fragments with transfer activity |
| 02/26/2015 | US20150056214 Monoclonal antibodies that bind b7h6 and uses thereof |
| 02/26/2015 | US20150056212 Uses and Compositions for Treatment of Rheumatoid Arthritis |
| 02/26/2015 | US20150056211 Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins |
| 02/26/2015 | US20150056210 Anti-adamts-5 antibody, derivatives and uses thereof |
| 02/26/2015 | US20150056209 Peptide mimotopes to oxidation specific epitopes |
| 02/26/2015 | US20150056208 Novel antibodies |
| 02/26/2015 | US20150056206 Multi-specific fab fusion proteins and methods of use |
| 02/26/2015 | US20150056205 Steroid sparing agents and methods of using same |
| 02/26/2015 | US20150056204 Dr5 receptor agonist combinations |
| 02/26/2015 | US20150056202 Anti-tnf/il-17 dual variable domain immunoglobulin and uses thereof |
| 02/26/2015 | US20150056201 Methods for detecting th1 cells |
| 02/26/2015 | US20150056200 Methods for increasing adiponectin |
| 02/26/2015 | US20150056198 Aberrant cell-restricted immunoglobulins provided with a toxic moiety |
| 02/26/2015 | US20150056197 Vaccines against hpv |
| 02/26/2015 | US20150056196 Antibody purification by cation exchange chromatography |
| 02/26/2015 | US20150056195 Compositions and methods for inihibiting tumorigenicity of senescent cancer cells induced by chemotherapy |
| 02/26/2015 | US20150056191 Igf1 biomarker for igf1r inhibitor therapy |
| 02/26/2015 | US20150056190 Diagnostic methods and compositions for treatment of cancer |
| 02/26/2015 | US20150056189 Cdr-modified anti-siglec-15 antibody |
| 02/26/2015 | US20150056188 Jcv neutralizing antibodies |
| 02/26/2015 | US20150056187 Humanized Antibodies That Recognize Alpha-Synuclein |
| 02/26/2015 | US20150056185 Immunoglobulin constant region fc receptor binding agents |
| 02/26/2015 | US20150056184 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof |
| 02/26/2015 | US20150056183 Therapeutic canine immunoglobulins and methods of using same |
| 02/26/2015 | US20150056182 Drug containing carrier into cell for forming immune complex |
| 02/26/2015 | US20150056181 Nanocarriers with multi-photon response elements |
| 02/26/2015 | US20150056180 Compositions comprising secretory - like imunoglobulins |
| 02/26/2015 | US20150056163 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/26/2015 | US20150056159 The IgM and IgE Heavy Chain Domain 2 as Covalently Linked Homodimerization Modules for the Generation of Fusion Proteins with Dual Specificity |
| 02/26/2015 | US20150056134 Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A |
| 02/26/2015 | US20150056133 Cx3cr1-targeting imaging agents and their use in the diagnosis and treatment of disease |
| 02/26/2015 | US20150056132 Immuno-pet imaging of antibodies and immunoconjugates and uses therefor |
| 02/25/2015 | EP2840091A1 Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof |
| 02/25/2015 | EP2840090A1 Antibody purification by cation exchange chromatography |
| 02/25/2015 | EP2839842A1 Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof |
| 02/25/2015 | EP2839840A1 Recombinant trivalent vaccine against human influenza |
| 02/25/2015 | EP2839009A1 Generating targeted sequence diversity in proteins |
| 02/25/2015 | EP2838920A1 Anti-baff-anti-il-17 bispecific antibodies |
| 02/25/2015 | EP2838919A1 Anti-mige antibodies that bind to the junction between ch4 and c epsilon mx domains |
| 02/25/2015 | EP2838918A1 Methods and means for the production of ig-like molecules |
| 02/25/2015 | EP2838917A1 Methods and means for the production of ig-like molecules |
| 02/25/2015 | EP2838561A1 Combination therapy of anti-mif antibodies and chemotherapeutics |
| 02/25/2015 | EP2838560A2 Methods of treating ankylosing spondylitis using il-17 antagonists |
| 02/25/2015 | EP2838559A1 Combination therapy of anti-mif antibodies and glucocorticoids |
| 02/25/2015 | EP2838557A1 The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity |
| 02/24/2015 | US8962819 Anti-C5 alpha antibodies |
| 02/24/2015 | US8962814 Interleukin-1α antibodies and methods of use |
| 02/24/2015 | US8962812 Methods of extracting chemical compounds from organisms with resistant cell walls |
| 02/24/2015 | US8962810 Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereof |
| 02/24/2015 | US8962808 EGFR-related polypeptides and methods of use |
| 02/24/2015 | US8962807 Single variable domain antibodies against OX40L, constructs and therapeutic use |
| 02/24/2015 | US8962806 Humanized monoclonal antibodies and methods of use |